Furthermore, to investigate whether acRoots regulates apoptosis and autophagy in HCC cells by suppressing the AKT/mTOR pathway, we pre-treated cells with Recilisib, an AKT activator, for 24 h prior to acRoots treatment. Here, AKT1 is linked to hepatocellular carcinoma.